Old Web
English
Sign In
Acemap
>
authorDetail
>
Melody Wu
Melody Wu
Analysis Group
Medicine
Clinical endpoint
Biologics License Application
Clinical trial
Oncology
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Characteristics of High-Risk Polycythemia Vera Patients with Suboptimal Response to First-Line Therapy Who Switched to Ruxolitinib Vs Those Who Did Not Switch: Findings from PV-Switch, a Multinational, Retrospective Chart Review Study
2021
Blood
Steffen Koschmieder
Clemens Schulte
Eyck Von der Heyde
Lambert Busque
Françoise Boyer-Perrard
Timothy Devos
Francesco Passamonti
Mike Zuurman
Carole Paley
Geralyn Gilotti
Wendy Y. Cheng
Chi Gao
Mu Cheng
Melody Wu
Mei Sheng Duh
Claire N. Harrison
Show All
Source
Cite
Save
Citations (0)
Real-world Evidence in Support of Oncology Product Registration: A Systematic Review of New Drug Application and Biologics License Application Approvals from 2015-2020.
2021
Clinical Cancer Research
Bhakti Arondekar
Mei Sheng Duh
Rachel H. Bhak
Maral DerSarkissian
Lynn Huynh
Kelsey Wang
John Wojciehowski
Melody Wu
Bryon Wornson
A. Niyazov
George D. Demetri
Show All
Source
Cite
Save
Citations (0)
1